Are You Positioned to Capitilize...https://technical420.com/cannabis-article/are-you-positioned-capitalize-when-history-made
Lexaria and Neutrisci Move Partnership Forward Today, Lexaria Bioscience Corp (LXRP: OTCQB) (LXX.CN: CSE) and Neutrisci International (NU.V: TSX Venture) (NRXCF: OTCQB) executed its previously announced joint venture to produce and commercialize a line of edible cannabinoid mouth-melt products. The products will utilize Lexaria’s patented technology and Neutrisci’s proprietary pterostilbene tablet form factor.
The joint venture will operate under the name Ambarii Trade Corporation and initial operations will be equally funded by the companies. Lexaria and Neutrisci will contribute their respective technologies through a license agreement and will share profits derived from the JV on a 50/50 basis.
Ambarii intends to secure licensees in California, Colorado and in Canada to manufacture and sell mouth-melt products containing THC. These products will combine the benefits of each of Lexaria’s and Neutrisci’s existing technologies and ingredient mixes. In June, a licensed California entity is scheduled to manufacture and test a THC version of the products.
Ambarii also intends to develop hemp oil-based products for distribution through networks including Neutrisci’s existing network of retail distributors as well as other methods. Initial production runs on these products have already achieved positive results in a human focus group.
This joint venture is attractive and may provide an avenue to create value for shareholders of both companies. Although there are no immediate plans to do so, Ambarii will be structured to allow for a potential future spin-off in the form of a stock dividend,